Sweden
· Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 39.48 billion. The enterprise value is 52.05 billion.
| Market Cap | 39.48B |
| Enterprise Value | 52.05B |
Important Dates
The next estimated earnings date is Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Medicover AB has 150.98 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 74.36M |
| Shares Outstanding | 150.98M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 11.16% |
| Owned by Institutions (%) | 28.55% |
| Float | 50.84M |
Valuation Ratios
The trailing PE ratio is 118.20 and the forward PE ratio is 48.61. Medicover AB's PEG ratio is 0.73.
| PE Ratio | 118.20 |
| Forward PE | 48.61 |
| PS Ratio | 1.68 |
| PB Ratio | 7.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.54 |
| P/OCF Ratio | 13.43 |
| PEG Ratio | 0.73 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.41, with an EV/FCF ratio of 32.35.
| EV / Earnings | 156.78 |
| EV / Sales | 2.21 |
| EV / EBITDA | 17.41 |
| EV / EBIT | 53.19 |
| EV / FCF | 32.35 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 2.45.
| Current Ratio | 0.85 |
| Quick Ratio | 0.73 |
| Debt / Equity | 2.45 |
| Debt / EBITDA | 4.52 |
| Debt / FCF | 8.40 |
| Interest Coverage | 1.46 |
Financial Efficiency
Return on equity (ROE) is 5.12% and return on invested capital (ROIC) is 3.35%.
| Return on Equity (ROE) | 5.12% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | 3.35% |
| Return on Capital Employed (ROCE) | 5.60% |
| Revenue Per Employee | 501,170 |
| Profits Per Employee | 7,064 |
| Employee Count | 47,256 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 27.47 |
Taxes
In the past 12 months, Medicover AB has paid 115.00 million in taxes.
| Income Tax | 115.00M |
| Effective Tax Rate | 28.27% |
Stock Price Statistics
The stock price has increased by +30.25% in the last 52 weeks. The beta is 1.56, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | +30.25% |
| 50-Day Moving Average | 243.27 |
| 200-Day Moving Average | 206.06 |
| Relative Strength Index (RSI) | 66.54 |
| Average Volume (20 Days) | 103,840 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 23.56 billion and earned 331.99 million in profits. Earnings per share was 2.21.
| Revenue | 23.56B |
| Gross Profit | 5.17B |
| Operating Income | 978.61M |
| Pretax Income | 406.85M |
| Net Income | 331.99M |
| EBITDA | 2.04B |
| EBIT | 978.61M |
| Earnings Per Share (EPS) | 2.21 |
Balance Sheet
The company has 1.17 billion in cash and 13.51 billion in debt, giving a net cash position of -12.34 billion or -81.72 per share.
| Cash & Cash Equivalents | 1.17B |
| Total Debt | 13.51B |
| Net Cash | -12.34B |
| Net Cash Per Share | -81.72 |
| Equity (Book Value) | 5.52B |
| Book Value Per Share | 35.24 |
| Working Capital | -911.34M |
Cash Flow
In the last 12 months, operating cash flow was 2.94 billion and capital expenditures -1.33 billion, giving a free cash flow of 1.61 billion.
| Operating Cash Flow | 2.94B |
| Capital Expenditures | -1.33B |
| Free Cash Flow | 1.61B |
| FCF Per Share | 10.66 |
Margins
Gross margin is 21.94%, with operating and profit margins of 4.15% and 1.41%.
| Gross Margin | 21.94% |
| Operating Margin | 4.15% |
| Pretax Margin | 1.73% |
| Profit Margin | 1.41% |
| EBITDA Margin | 8.67% |
| EBIT Margin | 4.15% |
| FCF Margin | 6.83% |
Dividends & Yields
This stock pays an annual dividend of 1.67, which amounts to a dividend yield of 0.65%.
| Dividend Per Share | 1.67 |
| Dividend Yield | 0.65% |
| Dividend Growth (YoY) | 17.10% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 58.82% |
| Buyback Yield | -0.35% |
| Shareholder Yield | 0.30% |
| Earnings Yield | 0.84% |
| FCF Yield | 4.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.04 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 7 |